News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 

PHARMAC cautious approach pays off

Media Release

PHARMAC cautious approach pays off

As the German drug and chemicals company, Bayer counts the cost of withdrawing its heart drug due to dangerous side-effects, PHARMAC says the move reinforces the need for continuing caution over which drugs receive Government funding, says Chief Executive Wayne McNee.

Pharmaceutical company Bayer has just announced that it is withdrawing its new cholesterol-lowering drug from the market as it has been linked to 31 deaths in the United States. The drug had been expected to become Bayer’s best selling product.

Wayne McNee says the development is a timely reminder that PHARMAC must continue to be vigilant and cautious when it comes to deciding which drugs are subsidised.

He says while the withdrawn drug has been approved in New Zealand for use, an application to PHARMAC for Government funding was turned down.

“The reality is once these drugs get the green light for Government funding they become much more widely prescribed and we have to be extremely cautious in making these decisions. New drugs go through a very robust process in drug registration agencies around the world. However in New Zealand there is a big difference between registration and funding when it comes to patient access to drugs.”

He says this is by no means an isolated case with similar incidences seen with other drugs.

“PHARMAC did not fund the diet drug dexfenfluramine which was later found to cause heart valve disorders. In another case PHARMAC was cautious about the use of Parkinson’s Disease treatment Tolcapone and placed prescribing restrictions on it. This drug was later shown to cause liver problems in some patients.”

Wayne McNee says sometimes PHARMAC will place restrictions on who can receive certain drugs as part of this cautious approach.

“These are potent medicines and as a result can have serious side effects and that is why they are prescription medicines. While all drugs go through clinical trials, the true side effects are sometimes not clear until they are more widely promoted and prescribed.”

[ends]

For more information contact (025) 429-212.

© Scoop Media

 
 
 
Culture Headlines | Health Headlines | Education Headlines

 


Howard Davis: Controlling the High Ground

Stephen Johnson's raw and angry film not only poses important questions with scrupulous authenticity, but also provides a timely reminder of the genocidal consequences of casual bigotry and xenophobia. More>>

Howard Davis: Dryzabone - Robert Conolly's The Dry

After the terrible devastation caused by last year’s bushfires, which prompted hundreds of Australians to shelter in the ocean to escape incineration and destroyed uncountable amounts of wildlife, The Dry has been released during a totally different kind of dry spell. More>>


Howard Davis: Benjamin Ree's The Painter and The Thief

The Norwegian filmmaker had long been fascinated by art thieves who commit high-stakes crimes with a delicate touch when a chance Google search in 2015 uncovered a botched heist in Oslo. More>>


Howard Davis: Hit the Road, Jack - Chloé Zhao's Nomadland

Nomadland is perhaps the ultimately 'road' movie as it follows a group of dispossessed and disenfranchised vagabonds who find a form of communal refuge in camp sites and trailer parks after the economic contraction of 2008. More>>


Howard Davis: Byrneing Down the House - Spike Lee's American Utopia

Lee does an admirable job capturing Byrne's stunning live performance of his latest album, but the real star of the show is the staging. More>>


Howard Davis: The Phoenix Foundation Friend Ship Tour Docks in Wellington

A sense of local pride was certainly running high at the Opera House on Saturday night, as the lads ran through a tasty little set drawn mostly from their latest album Friend Ship (splash out for Xmas on the shocking pink extra-thick vinyl edition). More>>


 
 
 
 
 
 

LATEST HEADLINES

  • CULTURE
  • HEALTH
  • EDUCATION
 
 
  • Wellington
  • Christchurch
  • Auckland